Global Transdermal Medical Patch Market Size study, by Type (Matrix, Single-Layer Drug In-Adhesive, Multi-Layer Drug In-Adhesive, Reservoir, Vapor Patch), by Application (Pain Management, Hormonal Therapy, Nicotine Cessation, Cardiovascular Disorders, Neu

Global Transdermal Medical Patch Market Size study, by Type (Matrix, Single-Layer Drug In-Adhesive, Multi-Layer Drug In-Adhesive, Reservoir, Vapor Patch), by Application (Pain Management, Hormonal Therapy, Nicotine Cessation, Cardiovascular Disorders, Neurologic Conditions, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032

Global Transdermal Medical Patch Market is valued at approximately USD 7.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2024-2032. Transdermal medical patches, also known as medicated or skin patches, are innovative medical devices designed to deliver drugs or therapeutic substances through the skin into the bloodstream. This non-invasive drug delivery method is especially beneficial for chronic conditions requiring long-term treatment, providing patients with a convenient and pain-free administration method. The market for transdermal patches is being driven by several key factors, including the growing prevalence of chronic diseases, the aging population, and advancements in transdermal patch technology.

The primary advantage of transdermal patches over traditional oral or injectable medications is their ability to avoid gastrointestinal toxicity, reducing instances of nausea and vomiting. These patches facilitate self-administration of medication, enhancing patient comfort and adherence, particularly for chronic conditions like heart disease, diabetes, and arthritis. Furthermore, the convenience and consistent plasma drug concentrations offered by transdermal patches make them increasingly popular for managing chronic diseases, which is driving the global market's growth. Moreover, the escalating number of smokers and rising use of insulin delivery present various lucrative opportunities over the forecast years. However, the potential skin irritation and hypersensitivity as well as drug failure & recalls of transdermal drug delivery systems are challenging the market growth throughout the forecast period of 2024-2032.

The key regions considered for the Global Transdermal Medical Patch Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Transdermal Medical Patch Market in terms of revenue. The market growth in the region is being attributed to factors including a well-established healthcare infrastructure, high levels of healthcare spending, and the presence of leading pharmaceutical companies that invest heavily in research and development. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by a rapidly expanding healthcare sector, increasing urbanization, and a rising geriatric population that requires effective and convenient treatment options.

Major market player included in this report are:

Novartis AG

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

Viatris Inc.

Endo International PLC

Boehringer Ingelheim

Nitto Denko Corporation

Luye Pharma Group Ltd.

Hisamitsu Pharmaceutical Co., Inc.

Medline Industries, LP

Corium LLC

UCB S.A.

Teikoku Pharma USA, Inc.

3M Company

GlaxoSmithKline plc

The detailed segments and sub-segment of the market are explained below:

By Type:

Matrix

Single-Layer Drug In-Adhesive

Multi-Layer Drug In-Adhesive

Reservoir

Vapor Patch

By Application:

Pain Management

Hormonal Therapy

Nicotine Cessation

Cardiovascular Disorders

Neurologic Conditions

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

Saudi Arabia

South Africa

RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with country-level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more